All 1 tracked stories fall under one category: markets. Collegium Pharmaceutical, Inc. is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Their average consequence score of 5 runs below the beat's 6.2 for that window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Eventide Asset Management LLC
All 1 tracked stories fall under one category: markets. Collegium Pharmaceutical, Inc. is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Their average consequence score of 5 runs below the beat's 6.2 for that window. They are less corroborated than the beat average, carrying 2 original sources each against 2.7 for the same window. We currently track 1 Finance story that mention Eventide Asset Management LLC, all published on March 15, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 82 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Eventide Asset Management LLC. Shared-story counts are live from our verified record — not editorial picks.
Eventide Asset Management LLC has reduced its equity position in Collegium Pharmaceutical, Inc. (COLL), though it maintains a significant $83.65 million stake. This institutional shift comes as the specialty pharmaceutical firm navigates a shifting landscape for chronic pain management and expands into neurology.
Eventide Asset Management LLC is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.